Nifty
:
24636.00
Sensex
:
78954.76
11.35 (0.05%)
373.76 (0.48%)
Nifty
Sensex
:
:
24636.00
78954.76
11.35 (0.05%)
373.76 (0.48%)

Balaxi Pharmaceuticals Ltd.

Finance - Investment

Rating :
35/99

BSE: Not Listed | NSE: BALAXI

NSE BSE
24.20
06-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  24.55
  •  24.8
  •  24.17
  •  24.17
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  35022
  •  854842.44
  •  52
  •  15.2

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 133.60
  • 55.12
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 174.83
  • N/A
  • 0.53

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 65.99%
  • 0.77%
  • 24.43%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 8.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -0.67
  • 3.84

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -28.38
  • -26.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -50.47
  • 12.16

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 11.05
  • 11.05

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 2.98
  • 1.95

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 9.97
  • 10.41

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
80.68
70.74
14.05%
70.71
76.27
-7.29%
72.54
73.29
-1.02%
56.17
77.38
-27.41%
Expenses
76.02
66.59
14.16%
70.59
63.71
10.80%
69.45
69.30
0.22%
55.01
66.80
-17.65%
EBITDA
4.66
4.15
12.29%
0.12
12.55
-99.04%
3.09
3.99
-22.56%
1.17
10.59
-88.95%
EBIDTM
5.78%
5.87%
0.17%
16.46%
4.26%
5.44%
2.08%
13.68%
Other Income
-0.99
-1.78
-
2.92
-1.69
-
0.10
3.94
-97.46%
1.59
-4.11
-
Interest
0.73
1.01
-27.72%
0.99
0.74
33.78%
1.02
1.38
-26.09%
0.89
0.45
97.78%
Depreciation
0.85
0.46
84.78%
0.65
0.46
41.30%
0.56
0.48
16.67%
0.49
0.46
6.52%
PBT
2.09
0.90
132.22%
1.40
9.66
-85.51%
1.61
6.07
-73.48%
1.38
5.56
-75.18%
Tax
0.79
0.61
29.51%
0.79
1.02
-22.55%
1.31
0.71
84.51%
1.17
0.97
20.62%
PAT
1.30
0.29
348.28%
0.61
8.64
-92.94%
0.30
5.36
-94.40%
0.21
4.59
-95.42%
PATM
1.61%
0.41%
0.87%
11.33%
0.42%
7.32%
0.37%
5.93%
EPS
0.23
0.05
360.00%
0.11
1.56
-92.95%
0.06
0.97
-93.81%
0.04
0.83
-95.18%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
280.10
270.17
292.56
241.29
336.43
279.39
231.33
45.63
13.60
Net Sales Growth
-5.91%
-7.65%
21.25%
-28.28%
20.42%
20.78%
406.97%
235.51%
 
Cost Of Goods Sold
154.48
150.88
165.70
128.68
202.42
195.60
172.15
32.83
10.24
Gross Profit
125.62
119.30
126.86
112.61
134.02
83.79
59.19
12.81
3.36
GP Margin
44.85%
44.16%
43.36%
46.67%
39.84%
29.99%
25.59%
28.07%
24.71%
Total Expenditure
271.07
260.59
260.35
196.75
279.02
228.56
188.66
37.38
12.04
Power & Fuel Cost
-
0.56
0.04
0.04
0.28
0.35
0.00
0.00
0.00
% Of Sales
-
0.21%
0.01%
0.02%
0.08%
0.13%
0%
0%
0%
Employee Cost
-
38.19
34.74
28.04
28.95
12.47
8.47
2.10
0.90
% Of Sales
-
14.14%
11.87%
11.62%
8.61%
4.46%
3.66%
4.60%
6.62%
Manufacturing Exp.
-
0.35
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0.13%
0%
0%
0%
0%
0%
0%
0%
General & Admin Exp.
-
31.66
24.19
24.17
35.00
14.98
5.28
2.34
0.61
% Of Sales
-
11.72%
8.27%
10.02%
10.40%
5.36%
2.28%
5.13%
4.49%
Selling & Distn. Exp.
-
28.48
0.64
0.66
0.84
1.02
0.10
0.10
0.21
% Of Sales
-
10.54%
0.22%
0.27%
0.25%
0.37%
0.04%
0.22%
1.54%
Miscellaneous Exp.
-
10.49
35.03
15.17
11.52
4.16
2.65
0.02
0.08
% Of Sales
-
3.88%
11.97%
6.29%
3.42%
1.49%
1.15%
0.04%
0.59%
EBITDA
9.04
9.58
32.21
44.54
57.41
50.83
42.67
8.25
1.56
EBITDA Margin
3.23%
3.55%
11.01%
18.46%
17.06%
18.19%
18.45%
18.08%
11.47%
Other Income
3.62
2.82
2.36
0.63
2.64
4.97
2.23
0.59
0.89
Interest
3.63
4.96
4.01
2.77
1.38
0.76
0.28
0.05
0.00
Depreciation
2.55
2.15
1.89
2.10
1.75
0.51
0.30
0.01
0.00
PBT
6.48
5.29
28.67
40.31
56.92
54.52
44.33
8.79
2.44
Tax
4.06
3.88
3.60
4.40
10.96
6.86
6.19
2.69
0.47
Tax Rate
62.65%
73.35%
12.56%
217.82%
19.26%
12.58%
13.96%
30.60%
19.26%
PAT
2.42
1.42
25.07
-2.39
45.96
47.66
38.14
6.10
1.97
PAT before Minority Interest
2.42
1.42
25.07
-2.39
45.96
47.66
38.14
6.10
1.97
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
0.86%
0.53%
8.57%
-0.99%
13.66%
17.06%
16.49%
13.37%
14.49%
PAT Growth
-87.18%
-94.34%
-
-
-3.57%
24.96%
525.25%
209.64%
 
EPS
0.44
0.26
4.54
-0.43
8.33
8.63
6.91
1.11
0.36

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
249.08
231.74
201.36
182.88
113.16
64.98
27.75
3.52
Share Capital
11.04
11.04
10.90
10.18
10.00
10.00
10.00
3.04
Total Reserves
238.03
220.69
186.69
162.40
103.16
54.98
17.75
0.48
Non-Current Liabilities
25.80
24.07
2.78
3.66
0.04
0.01
0.00
0.00
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
22.35
21.24
0.00
0.87
0.00
0.00
0.00
0.00
Long Term Provisions
0.25
0.13
0.04
0.00
0.00
0.00
0.00
0.00
Current Liabilities
62.16
54.53
54.20
53.13
63.27
34.69
8.22
2.59
Trade Payables
21.21
16.18
29.04
34.52
49.11
24.88
4.85
2.08
Other Current Liabilities
5.42
4.61
4.62
2.81
3.26
0.14
0.96
0.04
Short Term Borrowings
33.44
30.38
17.66
10.75
3.64
3.66
0.00
0.00
Short Term Provisions
2.09
3.37
2.88
5.06
7.25
6.01
2.42
0.47
Total Liabilities
337.04
310.34
258.34
239.67
176.47
99.68
35.97
6.11
Net Block
81.68
40.98
40.88
41.41
28.76
2.45
0.19
0.01
Gross Block
83.91
42.88
42.98
43.76
29.51
2.75
0.19
0.01
Accumulated Depreciation
2.23
1.89
2.10
2.35
0.76
0.30
0.00
0.00
Non Current Assets
85.60
67.58
48.17
46.16
35.47
5.91
1.11
0.33
Capital Work in Progress
0.00
22.07
2.31
2.83
0.57
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
3.42
0.00
0.00
Long Term Loans & Adv.
3.52
4.12
4.58
1.52
1.27
0.05
0.92
0.32
Other Non Current Assets
0.40
0.40
0.40
0.40
4.87
0.00
0.00
0.00
Current Assets
251.43
242.77
210.17
193.51
141.00
93.77
34.86
5.78
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
83.48
78.48
82.17
105.02
98.70
13.62
0.83
0.00
Sundry Debtors
136.10
110.80
55.71
52.28
27.56
76.76
29.71
5.47
Cash & Bank
14.56
39.40
62.29
28.22
7.19
1.67
4.00
0.13
Other Current Assets
17.29
2.88
2.02
3.78
7.55
1.72
0.31
0.17
Short Term Loans & Adv.
11.11
11.21
7.99
4.21
3.65
0.95
0.31
0.17
Net Current Assets
189.27
188.23
155.97
140.38
77.74
59.08
26.64
3.19
Total Assets
337.03
310.35
258.34
239.67
176.47
99.68
35.97
6.11

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
-4.50
-35.00
4.87
6.08
34.14
0.00
-14.04
-1.51
PBT
5.29
28.67
2.02
56.92
54.52
44.33
8.79
2.44
Adjustment
21.98
7.43
-1.14
8.03
1.18
-0.59
0.03
0.00
Changes in Working Capital
-27.05
-67.89
10.68
-46.79
-15.97
-41.14
-22.12
-3.94
Cash after chg. in Working capital
0.22
-31.79
11.55
18.17
39.74
2.60
-13.29
-1.50
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.72
-3.21
-6.68
-12.09
-5.59
-2.59
-0.74
-0.01
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-20.78
-21.76
-1.05
-10.57
-28.45
-5.97
-0.18
-0.01
Net Fixed Assets
-12.87
-19.28
1.66
-8.47
-2.33
-0.59
-0.18
Net Investments
-54.44
-5.19
-0.34
0.07
-0.07
-19.44
-0.10
Others
46.53
2.71
-2.37
-2.17
-26.05
14.06
0.10
Cash from Financing Activity
0.44
33.88
30.25
25.51
-0.16
3.65
18.10
0.00
Net Cash Inflow / Outflow
-24.84
-22.89
34.07
21.02
5.53
-2.32
3.88
-1.51
Opening Cash & Equivalents
39.40
62.29
28.21
7.19
1.66
3.98
0.10
1.62
Closing Cash & Equivalent
14.56
39.40
62.29
28.21
7.19
1.66
3.98
0.10

Financial Ratios

Standalone /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
45.12
41.98
36.26
33.90
113.16
64.98
27.75
11.58
ROA
0.44%
8.82%
-0.96%
22.09%
34.52%
56.23%
29.01%
32.19%
ROE
0.59%
11.68%
-1.29%
32.17%
53.50%
82.26%
39.04%
55.84%
ROCE
3.48%
13.01%
2.31%
37.46%
59.62%
92.56%
56.56%
69.35%
Fixed Asset Turnover
4.26
6.82
5.56
9.18
17.32
157.71
461.40
1203.13
Receivable days
166.78
103.86
81.67
43.31
68.14
84.00
140.73
146.96
Inventory Days
109.40
100.21
141.58
110.51
73.37
11.40
6.66
0.00
Payable days
45.22
49.80
90.14
75.41
69.04
31.52
38.51
66.84
Cash Conversion Cycle
230.96
154.28
133.11
78.42
72.47
63.88
108.88
80.12
Total Debt/Equity
0.22
0.22
0.09
0.07
0.03
0.06
0.00
0.00
Interest Cover
2.07
8.15
1.73
42.34
72.69
160.34
184.97
1061.57

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018

News Update:


  • Balaxi Pharma. - Quarterly Results
    6th Aug 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.